141 related articles for article (PubMed ID: 29254314)
1. Expression profile of eukaryotic translation initiation factor and matrix metalloproteinase 9 in endometrial cancer tissue.
Shi ZM; Liu YN; Fu B; Shen YF; Li LM
J Biol Regul Homeost Agents; 2017; 31(4):1053-1059. PubMed ID: 29254314
[TBL] [Abstract][Full Text] [Related]
2. eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition.
Zhang HH; Li R; Li YJ; Yu XX; Sun QN; Li AY; Kong Y
Oncol Rep; 2020 Feb; 43(2):447-460. PubMed ID: 31894279
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Wang XH; Liu YN; Tian K; Yao CX; Li LM; Zheng YQ; Shi ZM
J Biol Regul Homeost Agents; 2017; 31(4):879-887. PubMed ID: 29254290
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
Gao M; Zhang X; Li D; He P; Tian W; Zeng B
Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of matrix metalloproteinase-9 (MMP9) correlates with clinical course in Chinese patients with endometrial cancer.
Yu F; Jiang Q; Zhou Y; Yang Z; Yu X; Wang H; Liu Z; Wang L; Fang W; Guo S
Dis Markers; 2012; 32(5):321-7. PubMed ID: 22674412
[TBL] [Abstract][Full Text] [Related]
6. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
[TBL] [Abstract][Full Text] [Related]
7. Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma.
Choi CH; Lee JS; Kim SR; Lee YY; Kim CJ; Lee JW; Kim TJ; Lee JH; Kim BG; Bae DS
J Cancer Res Clin Oncol; 2011 Mar; 137(3):463-9. PubMed ID: 20464414
[TBL] [Abstract][Full Text] [Related]
8. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
Hsu HS; Chen HW; Kao CL; Wu ML; Li AF; Cheng TH
Ann Surg Oncol; 2011 May; 18(5):1469-77. PubMed ID: 21080085
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical value of eukaryotic initiation factor 4E and matrix metalloproteinase-9 in supraglottic and hypopharyngeal carcinoma and metastasis lymph].
Sun S; Liu Q; Zhang A; He E
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1116-9. PubMed ID: 17357517
[TBL] [Abstract][Full Text] [Related]
10. Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.
Diab-Assaf M; Abou-Khouzam R; Saadallah-Zeidan N; Habib K; Bitar N; Karam W; Liagre B; Harakeh S; Azar R
Int J Clin Exp Pathol; 2015; 8(1):404-13. PubMed ID: 25755728
[TBL] [Abstract][Full Text] [Related]
11. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
[TBL] [Abstract][Full Text] [Related]
12. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.
Karahan N; Güney M; Baspinar S; Oral B; Kapucuoglu N; Mungan T
Eur J Gynaecol Oncol; 2007; 28(3):184-8. PubMed ID: 17624083
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
Heikkinen T; Korpela T; Fagerholm R; Khan S; Aittomäki K; Heikkilä P; Blomqvist C; Carpén O; Nevanlinna H
Breast Cancer Res Treat; 2013 Aug; 141(1):79-88. PubMed ID: 23974830
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
[TBL] [Abstract][Full Text] [Related]
16. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
Guo ZL; Chen K; Wang XQ; Hu W
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
[TBL] [Abstract][Full Text] [Related]
17. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
18. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo.
Fang D; Peng J; Wang G; Zhou D; Geng X
Int J Mol Med; 2019 Oct; 44(4):1325-1332. PubMed ID: 31432159
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of mTOR and eIF4E expression in invasive ductal carcinoma.
Hu A; Sun M; Yan D; Chen K
Tumori; 2014; 100(5):541-6. PubMed ID: 25343550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]